Neurodegeneration and the Brain Barriers Contributors

[1]  T. Berzin,et al.  Microvascular injury and blood–brain barrier leakage in Alzheimer's disease , 2007, Neurobiology of Aging.

[2]  A. Hafezi-Moghadam,et al.  ApoE deficiency leads to a progressive age-dependent blood-brain barrier leakage. , 2007, American journal of physiology. Cell physiology.

[3]  R. Deane,et al.  Role of the blood-brain barrier in the pathogenesis of Alzheimer's disease. , 2007, Current Alzheimer research.

[4]  H. Braak,et al.  Stanley Fahn Lecture 2005: The staging procedure for the inclusion body pathology associated with sporadic Parkinson's disease reconsidered , 2006, Movement disorders : official journal of the Movement Disorder Society.

[5]  P. Carmeliet,et al.  VEGF at the neurovascular interface: therapeutic implications for motor neuron disease. , 2006, Biochimica et biophysica acta.

[6]  G. Waldemar,et al.  Idiopathic normal-pressure hydrocephalus: clinical comorbidity correlated with cerebral biopsy findings and outcome of cerebrospinal fluid shunting , 2006, Journal of Neurology, Neurosurgery & Psychiatry.

[7]  J. Nyengaard,et al.  Endothelial Proliferation and Increased Blood–Brain Barrier Permeability in the Basal Ganglia in a Rat Model of 3,4-Dihydroxyphenyl-l-Alanine-Induced Dyskinesia , 2006, The Journal of Neuroscience.

[8]  R. Pluta.  Is the ischemic blood–brain barrier insufficiency responsible for full-blown Alzheimer's disease? , 2006, Neurological research.

[9]  Miles C. Miller,et al.  RAGE, LRP-1, and amyloid-beta protein in Alzheimer’s disease , 2006, Acta Neuropathologica.

[10]  J. Provias,et al.  The possible role of capillary cerebral amyloid angiopathy in Alzheimer lesion development: a regional comparison , 2006, Acta Neuropathologica.

[11]  Mark Stacy,et al.  Randomized controlled trial of intraputamenal glial cell line–derived neurotrophic factor infusion in Parkinson disease , 2006, Annals of neurology.

[12]  Rebeca Martínez-Turrillas,et al.  Sequential changes in BDNF mRNA expression and synaptic levels of AMPA receptor subunits in rat hippocampus after chronic antidepressant treatment , 2005, Neuropharmacology.

[13]  P. Mecocci,et al.  Oxidative stress in brain aging, neurodegenerative and vascular diseases: an overview. , 2005, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

[14]  Don L. Armstrong,et al.  Role of the MEOX2 homeobox gene in neurovascular dysfunction in Alzheimer disease , 2005, Nature Medicine.

[15]  F. X. Guix,et al.  The physiology and pathophysiology of nitric oxide in the brain , 2005, Progress in Neurobiology.

[16]  V. Mathura,et al.  Anti-angiogenic activity of the mutant Dutch A(beta) peptide on human brain microvascular endothelial cells. , 2005, Brain research. Molecular brain research.

[17]  Berislav V. Zlokovic,et al.  Neurovascular mechanisms of Alzheimer's neurodegeneration , 2005, Trends in Neurosciences.

[18]  J. Bart,et al.  Blood–brain barrier dysfunction in parkinsonian midbrain in vivo , 2005, Annals of neurology.

[19]  R. Deane,et al.  RAGE (Yin) Versus LRP (Yang) Balance Regulates Alzheimer Amyloid &bgr;-Peptide Clearance Through Transport Across the Blood–Brain Barrier , 2004, Stroke.

[20]  N. Patel,et al.  Impaired angiogenesis in a transgenic mouse model of cerebral amyloidosis , 2004, Neuroscience Letters.

[21]  W. Lukiw,et al.  Angiogenic signaling in Alzheimer's disease , 2004, Neuroreport.

[22]  D. Quartermain,et al.  Links Between the Pathology of Alzheimer's Disease and Vascular Dementia , 2004, Neurochemical Research.

[23]  Y. Cheung,et al.  MDR1, the blood–brain barrier transporter, is associated with Parkinson’s disease in ethnic Chinese , 2004, Journal of Medical Genetics.

[24]  D. Dickstein,et al.  Blood—Brain Barrier Permeability Precedes Senile Plaque Formation in an Alzheimer Disease Model , 2003 .

[25]  M. Zigmond,et al.  Can the brain be protected through exercise? Lessons from an animal model of parkinsonism☆ , 2003, Experimental Neurology.

[26]  M. Reed,et al.  Aging and angiogenesis. , 2003, Frontiers in bioscience : a journal and virtual library.

[27]  G. Silverberg,et al.  Alzheimer's disease, normal‐pressure hydrocephalus, and senescent changes in CSF circulatory physiology: a hypothesis , 2003, The Lancet Neurology.

[28]  D. D. Di Monte,et al.  Effects of l‐dopa and other amino acids against paraquat‐induced nigrostriatal degeneration , 2003, Journal of neurochemistry.

[29]  L. Wilkins.  Assessment of low-flow CSF drainage as a treatment for AD: Results of a randomized pilot study , 2003, Neurology.

[30]  J. Jankovic,et al.  Randomized, double-blind trial of glial cell line-derived neurotrophic factor (GDNF) in PD , 2003, Neurology.

[31]  S. Salloway,et al.  Effect of APOE genotype on microvascular basement membrane in Alzheimer's disease , 2002, Journal of the Neurological Sciences.

[32]  P. Brundin.  GDNF treatment in Parkinson's disease: time for controlled clinical trials? , 2002, Brain : a journal of neurology.

[33]  P. Grammas,et al.  Cerebrovascular transforming growth factor-beta contributes to inflammation in the Alzheimer's disease brain. , 2002, The American journal of pathology.

[34]  K. Jellinger,et al.  Alzheimer disease and cerebrovascular pathology: an update , 2002, Journal of Neural Transmission.

[35]  P. Grammas,et al.  Inflammatory factors are elevated in brain microvessels in Alzheimer’s disease , 2001, Neurobiology of Aging.

[36]  H. Przuntek,et al.  Integrity of the blood–cerebrospinal fluid barrier in early Parkinson's disease , 2001, Neuroscience Letters.

[37]  D. Butterfield,et al.  Protein oxidation in the brain in Alzheimer's disease , 2001, Neuroscience.

[38]  W. Markesbery,et al.  Ratio of 8-hydroxyguanine in intact DNA to free 8-hydroxyguanine is increased in Alzheimer disease ventricular cerebrospinal fluid. , 2001, Archives of neurology.

[39]  K. Ashe,et al.  Ibuprofen Suppresses Plaque Pathology and Inflammation in a Mouse Model for Alzheimer's Disease , 2000, The Journal of Neuroscience.

[40]  G. Garcı́a-Cardeña,et al.  Endothelial Dysfunction, Hemodynamic Forces, and Atherogenesis a , 2000, Annals of the New York Academy of Sciences.

[41]  C. Plata-salamán,et al.  Inflammation and Alzheimer’s disease , 2000, Neurobiology of Aging.

[42]  K. Hensley,et al.  Determination of Biological Oxidative Stress Using High Performance Liquid Chromatography with Electrochemical Detection (HPLC‐ECD) , 1999 .

[43]  P. Hof,et al.  Brain Microvascular Changes in Alzheimer's Disease and Other Dementias a , 1997, Annals of the New York Academy of Sciences.

[44]  Patrick L. McGeer,et al.  Arthritis and anti-inflammatory agents as possible protective factors for Alzheimer's disease , 1996, Neurology.

[45]  J. Pollock,et al.  Nitric oxide synthase activity is elevated in brain microvessels in Alzheimer's disease. , 1994, Biochemical and biophysical research communications.

[46]  P. R. Hof,et al.  Pathological alterations of the cerebral microvasculature in Alzheimer's disease and related dementing disorders , 1994, Acta Neuropathologica.

[47]  Guangheng Liu,et al.  Anoxia/reoxygenation induces hydroxyl free radical formation in brain microvessels. , 1993, Free radical biology & medicine.

[48]  M. Pericak-Vance,et al.  Apolipoprotein E: high-avidity binding to beta-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[49]  D. Leibfritz,et al.  Free radicals and antioxidants in normal physiological functions and human disease. , 2007, The international journal of biochemistry & cell biology.

[50]  P. Grammas,et al.  Thrombin and inflammatory proteins are elevated in Alzheimer's disease microvessels: implications for disease pathogenesis. , 2006, Journal of Alzheimer's disease : JAD.

[51]  R. Pluta,et al.  Micro-blood-brain barrier openings and cytotoxic fragments of amyloid precursor protein accumulation in white matter after ischemic brain injury in long-lived rats. , 2006, Acta neurochirurgica. Supplement.

[52]  P. Grammas,et al.  Angiogenic proteins are expressed by brain blood vessels in Alzheimer's disease. , 2006, Journal of Alzheimer's disease : JAD.

[53]  D. Coppola,et al.  Inhibition of angiogenesis by Abeta peptides. , 2004, Angiogenesis.

[54]  J. Qiao,et al.  Homocysteine and Alzheimer's disease. , 1999, Nutrition reviews.

[55]  W. Markesbery,et al.  The nitration product 5-nitro-gamma-tocopherol is increased in the Alzheimer brain. , 2002, Nitric oxide : biology and chemistry.